PU.1/Interferon Regulatory Factor Interactions; Mechanisms of Transcriptional Regulation
The DOI matches its Crossref record; 117 of the 117 references it cites were found in a registry or an index.
Abstract
The complexity of eukaryotic gene regulation is slowly being resolved. What has become clear is that transcriptional regulation is a multi-step process that involves the assembly of macromolecular complexes. This review will discuss the biology of the ETS family transcription factor PU.1, with emphasis on its interactions with two members of the Interferon Regulatory Factor (IRF) family, interferon consensus sequence binding protein (ICSBP), and IRF-4. The role of these interactions in transcriptional regulation is discussed, with respect to DNA binding motifs, protein-protein interaction and phosphorylation states that modulate PU.1/IRF interactions. Furthermore, potential transcriptional mechanisms for several genes are discussed, focusing on genes involved in innate immunity. Data from these studies suggest at least four distinct paradigms for transcriptional regulation by an ETS protein in conjunction with either ICSBP or IRF-4. These paradigms may describe regulatory mechanisms common to many distinct transcription factor families. Last, recent data from several laboratories have now documented the expression of ICSBP and IRF-4 in a range of cell types. These data suggest that ICSBP and IRF-4 may serve functions within these cell types that are distinct from their previously recognized functions.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Pip/NF-EM5/IRF-4, a member of IRF family, is a lymphoid-restricted transcription factor that is recruited to a composite element (IRF/ETS-binding site) within Ig light chain enhancers through a specific interaction with PU.1 protein [116, 117].”
From PU.1 and partners: regulation of haematopoietic stem cell fate in normal and malignant haematopoiesis (2009) · cites this paper as [116]
Citations
Cites
HOW CELLS RESPOND TO INTERFERONS
Stark, G. R., Kerr, I. M., Williams, B. R. G., Silverman, R. H., & Schreiber, R. D. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.227 · Cited by 3,932 · cited 4×
“A typical single-copy ISRE follows the consensus sequence 5′ GAAANT/C 3′; the GAS element consensus is 5′ TTTNCNNNAA 3′ (50,56).”
BackgroundInfluentialRequirement of transcription factor PU.1 in the development of multiple hematopoietic lineages
Scott, E. W., Simon, M. C., Anastasi, J., & Singh, H. (1994) · Science · doi:10.1126/science.8079170 · Cited by 1,532 · cited 1×
“However, these mice do possess megakaryocytes, immature mast cells, and erythroid cells (24), which suggests that PU.”
BackgroundTargeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities
McKercher, S. R., Torbett, B. E., Anderson, K. L., Henkel, G. W., Vestal, D. J., Baribault, H., Klemsz, M., Feeney, A. J., Wu, G. E., Paige, C. J., et al. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00949.x · Cited by 1,130
Harada, H., Fujita, T., Miyamoto, M., Kimura, Y., Maruyama, M., Furia, A., Miyata, T., & Taniguchi, T. (1989) · Cell · doi:10.1016/0092-8674(89)90107-4 · Cited by 958 · cited 2×
“IRF-1 is generally believed to function as a transcriptional activator (61).”
BackgroundLin, R., Heylbroeck, C., Pitha, P. M., & Hiscott, J. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.5.2986 · Cited by 915 · cited 1×
“IRFs 1–3 are phosphorylated by CK2, and ICSBP and IRF-4 contain multiple potential CK2 consensus sites that follow the consensus /TXX/E motif (107,108,119).”
BackgroundThe Ets family of transcription factors
WASYLYK, B., HAHN, S. L., & GIOVANE, A. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb19864.x · Cited by 842 · cited 1×
“ETS family members recognize, and bind via the ETS domain, to a core RGAA DNA motif centered within a longer nucleotide sequence (9,10).”
BackgroundRegulation of B lymphocyte and macrophage development by graded expression of PU.1
DeKoter, R. P., & Singh, H. (2000) · Science · doi:10.1126/science.288.5470.1439 · Cited by 749
Holtschke, T., Löhler, J., Kanno, Y., Fehr, T., Giese, N., Rosenbauer, F., Lou, J., Knobeloch, K.-P., Gabriele, L., Waring, J. F., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81348-3 · Cited by 644 · cited 1×
“As expected, these mice also displayed impaired responses against pathogens that require functional macrophages for host immunity, specifically Listeria monocytogenes and lymphocytic choriomeningitis virus (LCMV) (84,85).”
BackgroundRequirement for the Transcription Factor LSIRF/IRF4 for Mature B and T Lymphocyte Function
Mittrücker, H.-W., Matsuyama, T., Grossman, A., Kündig, T. M., Potter, J., Shahinian, A., Wakeham, A., Patterson, B., Ohashi, P. S., & Mak, T. W. (1997) · Science · doi:10.1126/science.275.5299.540 · Cited by 583
Interferon regulatory factors: the next generation
Mamane, Y., Heylbroeck, C., Génin, P., Algarté, M., Servant, M. J., LePage, C., DeLuca, C., Kwon, H., Lin, R., & Hiscott, J. (1999) · Gene · doi:10.1016/s0378-1119(99)00262-0 · Cited by 562 · cited 1×
“Some IRF proteins also contain a putative IRF-association domain (IAD) within the carboxy-terminus, through which protein–protein interactions with IRF and non-IRF proteins are believed to occur (56,57).”
Background
Cited by
Exploiting Synthetic Lethality for the Therapy of ABC Diffuse Large B Cell Lymphoma
Yang, Y., Shaffer, A. L., Emre, N. C. T., Ceribelli, M., Zhang, M., Wright, G., Xiao, W., Powell, J., Platig, J., Kohlhammer, H., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.05.024 · Cited by 521
“Remarkably, survival of ABC DLBCL cells depended on a single amino acid in IRF4 that mediates its interaction with SPIB on composite EICE motifs.”
BackgroundInfluentialInterferon regulatory factor-8 regulates bone metabolism by suppressing osteoclastogenesis
Zhao, B., Takami, M., Yamada, A., Wang, X., Koga, T., Hu, X., Tamura, T., Ozato, K., Choi, Y., Ivashkiv, L. B., et al. (2009) · Nature Medicine · doi:10.1038/nm.2007 · Cited by 292
Chistiakov, D. A., Myasoedova, V. A., Revin, V. V., Orekhov, A. N., & Bobryshev, Y. V. (2018) · Immunobiology · doi:10.1016/j.imbio.2017.10.005 · Cited by 311
PU.1 regulates the commitment of adult hematopoietic progenitors and restricts granulopoiesis
Dakic, A., Metcalf, D., Di Rago, L., Mifsud, S., Wu, L., & Nutt, S. L. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050075 · Cited by 297
“other key transcription factors, such as interferon regulatory factor (IRF)4, IRF8, AML-1, CCAAT/enhancer binding protein (C/EBP ), GATA-1, and c-Jun (13).”
BackgroundToll-Like Receptor Signaling and Regulation of Cytokine Gene Expression in the Immune System
Ozato, K., Tsujimura, H., & Tamura, T. (2002) · BioTechniques · doi:10.2144/oct0208 · Cited by 189
Review: ICSBP/IRF-8: Its Regulatory Roles in the Development of Myeloid Cells
Tamura, T., & Ozato, K. (2002) · Journal of Interferon & Cytokine Research · doi:10.1089/107999002753452755 · Cited by 183
Direct Inhibition of IRF-Dependent Transcriptional Regulatory Mechanisms Associated With Disease
Antonczyk, A., Krist, B., Sajek, M., Sekrecka, A., Piaszyk-Borychowska, A., Plens-Gałąska, M., Wesoły, J., & Bluyssen, H. A. R. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01176 · Cited by 178
Nehyba, J., Hrdlickova, R., & Bose, H. R. (2009) · Molecular Biology and Evolution · doi:10.1093/molbev/msp167 · Cited by 150
“…IRF4-SG proteins are present in sponges including 1) a short variable N-terminus that precedes the IRF DBD; 2) an approximately 150 amino acid long, proline- and serine/ threonine-rich middle region separating the DBD from IAD1; and 3) an approximately 50 amino acid long, variable C-terminus.”
BackgroundMonocyte differentiation and macrophage polarization
Orekhov, A. N., Orekhova, V. A., Nikiforov, N. G., Myasoedova, V. A., Grechko, A. V., Romanenko, E. B., Zhang, D., & Chistiakov, D. A. (2019) · Vessel Plus · doi:10.20517/2574-1209.2019.04 · Cited by 136
“1 can cooperate to enhance the expression of target genes([85]).”
BackgroundWhen Ets transcription factors meet their partners
Verger, A., & Duterque‐Coquillaud, M. (2002) · BioEssays · doi:10.1002/bies.10068 · Cited by 134
Kuo, T. C., & Calame, K. L. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.9.5556 · Cited by 131
Immune cell-specific amplification of interferon signaling by the IRF-4/8-PU. 1 complex
Kanno, Y., Levi, B.-Z., Tamura, T., & Ozato, K. (2005) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2005.25.770 · Cited by 128
“30,73 Based on these differences, the new subtype of ISRE was termed ETS/IRF response elements (EIRE).”
Barnes, B. J., Field, A. E., & Pitha-Rowe, P. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212609200 · Cited by 143
Hosokawa, H., Ungerbäck, J., Wang, X., Matsumoto, M., Nakayama, K. I., Cohen, S. M., Tanaka, T., & Rothenberg, E. V. (2018) · Immunity · doi:10.1016/j.immuni.2018.04.024 · Cited by 116
“, IRF4 or IRF8 (Marecki and Fenton, 2000) and C/EBPa or C/EBPb (Heinz et al.”
Lehtonen, A., Veckman, V., Nikula, T., Lahesmaa, R., Kinnunen, L., Matikainen, S., & Julkunen, I. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.10.6570 · Cited by 116
Marecki, S., Riendeau, C. J., Liang, M. D., & Fenton, M. J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.11.6829 · Cited by 111
Self-citationMeraro, D., Gleit-Kielmanowicz, M., Hauser, H., & Levi, B.-Z. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.12.6224 · Cited by 105
Mechanisms of Action of Hematopoietic Transcription Factor PU.1 in Initiation of T-Cell Development
Rothenberg, E. V., Hosokawa, H., & Ungerbäck, J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00228 · Cited by 99
Transcription factor PU.1 and immune cell differentiation (Review)
Li, G., Hao, W., & Hu, W. (2020) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2020.4763 · Cited by 98
Regulation of human β2-microglobulin transactivation in hematopoietic cells
Gobin, S. J. P., Biesta, P. J., & van den Elsen, P. J. (2003) · Blood · doi:10.1182/blood-2002-09-2924 · Cited by 98
TREM‐1 expression in macrophages is regulated at transcriptional level by NF‐κB and PU.1
Zeng, H., Ornatowska, M., Joo, M., & Sadikot, R. T. (2007) · European Journal of Immunology · doi:10.1002/eji.200737270 · Cited by 101
Identification of IRF-8 and IRF-1 target genes in activated macrophages
Dror, N., Alter-Koltunoff, M., Azriel, A., Amariglio, N., Jacob‐Hirsch, J., Zeligson, S., Morgenstern, A., Tamura, T., Häuser, H., Rechavi, G., et al. (2006) · Molecular Immunology · doi:10.1016/j.molimm.2006.02.026 · Cited by 89
Gupta, P., Gurudutta, G. U., Saluja, D., & Tripathi, R. P. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00757.x · Cited by 74
Is PU.1 a dosage-sensitive regulator of haemopoietic lineage commitment and leukaemogenesis?
Dakic, A., Wu, L., & Nutt, S. L. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.01.006 · Cited by 72
Review: ICSBP/IRF-8 Transactivation: A Tale of Protein-Protein Interaction
Levi, B.-Z., Hashmueli, S., Gleit-Kielmanowicz, M., Azriel, A., & Meraro, D. (2002) · Journal of Interferon & Cytokine Research · doi:10.1089/107999002753452764 · Cited by 70
Chen, G., Tan, C. S., Teh, B. K., & Lu, J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.286427 · Cited by 71
Smith, M. A., Wright, G., Wu, J., Tailor, P., Ozato, K., Chen, X., Wei, S., Piskurich, J. F., Ting, J. P.-Y., & Wright, K. L. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.165431 · Cited by 61
Sharma, S., Grandvaux, N., Mamane, Y., Génin, P., Azimi, N., Waldmann, T. A., & Hiscott, J. B. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.6.3120 · Cited by 64
van der Stoep, N., Quinten, E., Rezende, M. M., & van den Elsen, P. J. (2004) · Blood · doi:10.1182/blood-2004-03-0790 · Cited by 65
Schmidt, M., Bies, J., Tamura, T., Ozato, K., & Wolff, L. (2004) · Blood · doi:10.1182/blood-2003-01-0285 · Cited by 58
Shin, D.-M., Lee, C.-H., & Morse, H. C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027384 · Cited by 56
“IRF8, one of nine members of the IRF family of transcription factors, functions in modulating immune responses and as a central element in the IFN signaling cascade. The gene is constitutively expressed in macrophages where it has been identified at the promoter regions of a large number of genes critical to macrophag…”
BackgroundPU.1 and ICSBP control constitutive and IFN-γ-regulated Tlr9 gene expression in mouse macrophages
Schroder, K., Lichtinger, M., Irvine, K. M., Brion, K., Trieu, A., Ross, I. L., Ravasi, T., Stacey, K. J., Rehli, M., Hume, D. A., et al. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0107036 · Cited by 51
“1/IRF sites functional in the regulation of a number of genes [41, 42].”
BackgroundIeki, K., Matsukura, S., Kokubu, F., Kimura, T., Kuga, H., Kawaguchi, M., Odaka, M., Suzuki, S., Watanabe, S., Takeuchi, H. T., et al. (2004) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2004.1941.x · Cited by 51
Laricchia-Robbio, L., Tamura, T., Karpova, T., Sprague, B. L., McNally, J. G., & Ozato, K. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504014102 · Cited by 48
Transcriptional Regulation of Mouse μ Opioid Receptor Gene by PU.1
Hwang, C. K., Kim, C. S., Choi, H. S., McKercher, S. R., & Loh, H. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400755200 · Cited by 46
Rhodes, J. D., Lott, M. C., Russell, S., Moulton, V., Sanderson, J., Wormstone, I. M., & Broadway, D. C. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr515 · Cited by 54
“ATF3 2 Regulates immune responses (74) RFX1 1 Immune response ZIC2 1 RREB1 1 Transcriptional repressor (75) SOX9 1 MTF1 1 SREBF1 1 C/EBP alpha 1 Cell cycle arrest (76) MAF 1 PAX4 1 HNF4 1 KAT2B–PCAF 1 Cell cycle arrest (77,78) TCF3–E2A 1 Transcriptional repressor (79) ZIC3 1 SPI1–PU1 1 Innate immune responses (80) AP2…”
Origins of lymphocyte developmental programs: transcription factor evidence
Rothenberg, E. V., & Pant, R. (2004) · Seminars in Immunology · doi:10.1016/j.smim.2004.08.002 · Cited by 46
Alter-Koltunoff, M., Ehrlich, S., Dror, N., Azriel, A., Eilers, M., Hauser, H., Bowen, H., Barton, C. H., Tamura, T., Ozato, K., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307954200 · Cited by 41
Specificity and Function of IRF Family Transcription Factors: Insights from Genomics
Mancino, A., & Natoli, G. (2016) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2016.0004 · Cited by 42
“Interestingly, also some TFs, which have been described as IRF4 and IRF8 partners, such as PU.1 and E47, contain a PEST motif that mediates their efficient associations with IAD domain (Nagulapalli and Atchison 1998; Marecki and Fenton 2000; Meraro and others 2002).”
Maggi, L. B., Moran, J. M., Buller, R. M. L., & Corbett, J. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211744200 · Cited by 42
Karrich, J. J., Balzarolo, M., Schmidlin, H., Libouban, M. A. A., Nagasawa, M., Gentek, R., Kamihira, S., Maeda, T., Amsen, D., Wolkers, M. C., et al. (2012) · Blood · doi:10.1182/blood-2011-07-370239 · Cited by 42
Repression of IRF-4 target genes in human T cell leukemia virus-1 infection
Mamane, Y., Grandvaux, N., Hernandez, E., Sharma, S., Innocente, S. A., Lee, J. M., Azimi, N., Lin, R., & Hiscott, J. B. (2002) · Oncogene · doi:10.1038/sj.onc.1205843 · Cited by 41
Dekoninck, A., Calomme, C., Nizet, S., de Launoit, Y., Burny, A., Ghysdael, J., & Lint, C. M. V. (2003) · Oncogene · doi:10.1038/sj.onc.1206392 · Cited by 38
The Roles of Monocytes and Macrophages in Behçet’s Disease With Focus on M1 and M2 Polarization
Hirahara, L., Takase‐Minegishi, K., Kirino, Y., Iizuka-Iribe, Y., Soejima, Y., Yoshimi, R., & Nakajima, H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.852297 · Cited by 37
“IL1b levels were increased in BD patients compared with controls (SMD = 1.67, 95% CI: 0.18–3.16, I2 = 97%, p 0.001).”
BackgroundInfluentialMazzi, P., Donini, M., Margotto, D., Wientjes, F., & Dusi, S. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.8.4941 · Cited by 30
Yashiro, T., Yamamoto, M., Araumi, S., Hara, M., Yogo, K., Uchida, K., Kasakura, K., & Nishiyama, C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.649572 · Cited by 34
PU.1 Binds to a Distal Regulatory Element That Is Necessary for B Cell-Specific Expression of CIITA
Yoon, H., & Boss, J. M. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000079 · Cited by 29
Review: IRF-4 Activities in HTLV-I-Induced T Cell Leukemogenesis
Mamane, Y., Sharma, S., Grandvaux, N., Hernandez, E., & Hiscott, J. B. (2002) · Journal of Interferon & Cytokine Research · doi:10.1089/107999002753452746 · Cited by 30
Interferon regulatory factor 8 governs myeloid cell development
Xia, X., Wang, W., Yin, K., & Wang, S. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.03.003 · Cited by 24
Nrf2 regulates PU.1 expression and activity in the alveolar macrophage
Staitieh, B. S., Fan, X., Neveu, W. A., & Guidot, D. M. (2015) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00355.2014 · Cited by 22
PU.1 Regulates Cathepsin S Expression in Large Yellow Croaker (Larimichthys crocea) Macrophages
Zhang, X.-Y., Zhuo, X., Cheng, J., Wang, X., Liang, K., & Chen, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.819029 · Cited by 23
“1 to the Ets motif [(G/A)GAA] within the promoter of its target genes (26).”
BackgroundPU.1 Regulates Cathepsin S Expression in Professional APCs
Wang, Y., Baron, R. M., Zhu, G., Joo, M., Christman, J. W., Silverman, E. S., Perrella, M. A., Riese, R. J., & Cernadas, M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.1.275 · Cited by 24
“1 is its ability to associate with and enhance the activity of other transcription factors, including those belonging to the IRF family (19).”
BackgroundYashiro, T., Takeuchi, H., Nakamura, S., Tanabe, A., Hara, M., Uchida, K., Okumura, K., Kasakura, K., & Nishiyama, C. (2019) · The FASEB Journal · doi:10.1096/fj.201900379rr · Cited by 20
“1 regulates gene expressionby cooperatingwithother transcription factors, such as IRF4, IRF8, and C/enhanced binder protein a (21, 22).”
BackgroundMononuclear phagocyte regulation by the transcription factor Blimp‐1 in health and disease
Ulmert, I., Henriques‐Oliveira, L., Pereira, C., & Lahl, K. (2020) · Immunology · doi:10.1111/imm.13249 · Cited by 22
Borghini, L., Lu, J., Hibberd, M. L., & Dávila, S. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1800246 · Cited by 19
“IRFs, which bind ISRE and can interact with PU1 to form PU1:IRF complex (33), are regulators of the IFN response.”
BackgroundBuilding promoter aware transcriptional regulatory networks using siRNA perturbation and deepCAGE
Vitezic, M., Lassmann, T., Forrest, A. R. R., Suzuki, M., Tomaru, Y., Kawai, J., Carninci, P., Suzuki, H., Hayashizaki, Y., & Daub, C. O. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq729 · Cited by 17
“cooperative binding of both factors (20,23).”
The Prolyl Isomerase Pin1 Modulates Development of CD8+ cDC in Mice
Barberi, T. J., Dunkle, A. D., He, Y.-W., Racioppi, L., & Means, A. R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029808 · Cited by 14
“Primary WT and Pin12/2MEF were grown to 85% confluency in DMEM-MEF (DMEM containing 2 mM Lglutamine, 10% hiFBS, and Pen/Strep) and then lysed in Passive Lysis Buffer (PLB) supplemented with 100 mg/ml Pefabloc, 10 mg/ ml Leupeptin, and 100 nM Okadaic Acid.”
BackgroundInfluentialMarden, C. M., Stefanidis, D., Graham, D. S. C., & Casimir, C. M. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00727-7 · Cited by 15
PML is a key component for the differentiation of myeloid progenitor cells to macrophages
Khalfin-Rabinovich, Y., Weinstein, A., & Levi, B.-Z. (2011) · International Immunology · doi:10.1093/intimm/dxr004 · Cited by 13
Nakano, N., Nishiyama, C., Masuoka, N., Nishiyama, M., Yamane, H., Okumura, K., & Ogawa, H. (2005) · Immunogenetics · doi:10.1007/s00251-004-0754-2 · Cited by 13
HIV-1 Vpr combats the PU.1-driven antiviral response in primary human macrophages
Virgilio, M. C., Ramnani, B., Chen, T., Disbennett, W. M., Lubow, J., Welch, J. D., & Collins, K. L. (2024) · Nature Communications · doi:10.1038/s41467-024-49635-w · Cited by 14
“Moreover, PU.1 appeared twice in the list – asboth a member of the ETS family and as a co-factor in the ETS/IRF (interferon regulatory factor)family oftranscriptionfactors, arelationship thatiswell documented 30 (Fig.2A).”
Hashmueli, S., Gleit-Kielmanowicz, M., Meraro, D., Azriel, A., Melamed, D., & Levi, B.-Z. (2003) · International Immunology · doi:10.1093/intimm/dxg077 · Cited by 9
Chen, K. Y., Angulo, A. D., Guo, X., More, A., Ochsner, S. A., Lopez, E., Saul, D., Pang, W., Sun, Y., McKenna, N. J., et al. (2022) · Frontiers in Aging · doi:10.3389/fragi.2021.803482 · Cited by 8
“These included members of the IRF (Irf3, Irf5), STAT (Stat1, Stat6) and AP-1 (Jun, Junb) transcription factor families, as well as Fosl1, Cebpd and Nfkb1.”
BackgroundInfluentialLiu, S., & Wang, Z. (2022) · Disease Markers · doi:10.1155/2022/2561673 · Cited by 11
“IRF4 and IRF8 were found to cooperate with SPI1 and thereby upregulate the expression of pro-inflammatory genes (e.g., CD20, Ig light chain enhancers, IL-18, and IL-1β) [19–21].”
BackgroundInfluentialPU.1 directly regulates retinoic acid-induced expression of RIG-G in leukemia cells
Gu, Z.-M., Liu, C., Wu, S.-F., Zhao, M. L., Xu, H.-Z., Liu, W., Zhou, H.-C., Chen, G., & Wu, Y. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.12.021 · Cited by 7
“These factors may also contribute to ATRA induced upregulation of RIG-G [18–20].”
BackgroundKDM6A Lysine Demethylase Directs Epigenetic Polarity of MDSCs during Murine Sepsis
Bah, I., Alkhateeb, T., Youssef, D. A., Yao, Z. Q., McCall, C. E., & Gazzar, M. E. (2021) · Journal of Innate Immunity · doi:10.1159/000517407 · Cited by 5
Regulatory Co-options in the Evolution of Deuterostome Immune Systems
Rothenberg, E. V., & Davidson, E. H. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-320-0_4 · Cited by 5
Shimokawa, N., Nishiyama, C., Nakano, N., Maeda, K., Suzuki, R., Hara, M., Fukai, T., Tokura, T., Miyajima, H., Nakao, A., et al. (2010) · Immunogenetics · doi:10.1007/s00251-010-0444-1 · Cited by 5
“1/IRFcomplex binding site (Marecki and Fenton 2000) are present in the IRF-8 promoter (−175/−155).”
BackgroundOverexpression of IRF8 and Pu.1 in B cells of systemic lupus erythematosus patients
Azizan, A., Farhadi, E., Faezi, S. T., Alikhani, M., Jamshidi, A., Vodjgani, M., & Mahmoudi, M. (2025) · Lupus · doi:10.1177/09612033251366400 · Cited by 1
“22,23 Furthermore, another research indicates that PU.1 in fl uences the regulation of IRF4 and IRF7.”
Inferring transcriptional regulation on the promoter level and its applications to diseases
Vitezic, M. (2013) · Figshare
Transcription Factors: Deciphering the Transcription Factor Network of Dendritic Cell Development
Hieronymus, T., & Zenke, M. (2006) · Wiley eBooks · doi:10.1002/9783527619696.ch4 · Cited by 1
Expression and activation of STAT and IRF family transcription factors in mononuclear leukocytes
Lehtonen, A. (2005) · Helda - University of Helsinki Institutional Repository
Roles for Pin1 in Modulating Cells of the Innate Immune System
Barberi, T. J. (2011) · DukeSpace (Duke University)
The Transcriptional Regulation of HLA-E by Interferon-Gamma in Tumor Cells
Grant, Q. (2010) · VCU Scholars Compass (Virginia Commonwealth University) · doi:10.25772/9hab-qt04
Metadata
- Authors
- Marecki, S., & Fenton, M. J.
- Affiliations
- Boston University (US)
- ORCID
- Fenton, Matthew J.
- Venue
- Cell Biochemistry and Biophysics
- Published
- 2000
- Volume
- 33
- Issue
- 2
- Pages
- 127-148
- ISSN
- 1085-9195 (ISSN-L)
- OpenAlex
- W2330690422
- Semantic Scholar
- 1f32d4a50efbfa831a0783908370cea0e52d57cd
- Cited by
- 74
- References
- 117
- Citations by year
- 2025: 1 · 2024: 1 · 2022: 4 · 2021: 2 · 2020: 3 · 2019: 4 · 2018: 2 · 2017: 1 · 2016: 1 · 2015: 1 · 2013: 1 · 2012: 3
- FWCI
- 2.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cell Biochemistry and Biophysics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Keywords
- PU.1, interferon regulatory factors, IRF8, IRF4, ETS transcription factors, transcriptional regulation, protein-protein interaction, phosphorylation, DNA-binding motifs, innate immunity, transcription factor complex
- MeSH terms
- Interferon Regulatory Factor-8, Interferon Regulatory Factor-4, Proto-Oncogene Protein Spi-1, Animals, Binding Sites, DNA, DNA-Binding Proteins, Gene Expression Regulation, Humans, Interferons, Proto-Oncogene Proteins, Repetitive Sequences, Nucleic Acid, Repressor Proteins, Transcription Factors, Transcription, Genetic, Trans-Activators, Consensus Sequence, Proto-Oncogene Proteins c-ets, Interferon Regulatory Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.